| Page 1277 | Kisaco Research
 

John Rossi

VP Translational Medicine
Syncopation Life Sciences

John Rossi

VP Translational Medicine
Syncopation Life Sciences

John Rossi

VP Translational Medicine
Syncopation Life Sciences
 

Frank Borriello

CEO
Alloplex Biotherapeutics

Frank Borriello

CEO
Alloplex Biotherapeutics

Frank Borriello

CEO
Alloplex Biotherapeutics
 

Aviad Pato

Head of Research, Natural Killer Cells
Gamida Cell

Aviad Pato

Head of Research, Natural Killer Cells
Gamida Cell

Aviad Pato

Head of Research, Natural Killer Cells
Gamida Cell
 

Karrie Wong

Director of Cell Therapy
KSQ Therapeutics

Karrie Wong

Director of Cell Therapy
KSQ Therapeutics

Karrie Wong

Director of Cell Therapy
KSQ Therapeutics
 

Vicki Plaks

Sr. Director, Cell Therapy, Oncology Discovery
AbbVie

Vicki Plaks

Sr. Director, Cell Therapy, Oncology Discovery
AbbVie

Vicki Plaks

Sr. Director, Cell Therapy, Oncology Discovery
AbbVie
 

Stefanie Mandl

SVP Research
PACT Pharma

Stefanie Mandl

SVP Research
PACT Pharma

Stefanie Mandl

SVP Research
PACT Pharma
 

Samia Khan

Senior Scientist II
Editas Medicine

Samia Khan

Senior Scientist II
Editas Medicine

Samia Khan

Senior Scientist II
Editas Medicine
 

Michael O'Dwyer

Chief Scientific Officer
ONK Therapeutics

Michael O'Dwyer

Chief Scientific Officer
ONK Therapeutics

Michael O'Dwyer

Chief Scientific Officer
ONK Therapeutics
 

Justin Edwards

Director of Cell Biology
Arcellx

Justin Edwards

Director of Cell Biology
Arcellx

Justin Edwards

Director of Cell Biology
Arcellx
 

Jonathan Gilbert

VP of Exploratory Research
SQZ Biotechnologies

Jonathan Gilbert, PhD joined SQZ in 2013 and has been a key player in the growth and development of the company from its formative stages. As the Vice President of Exploratory Research, he is applying the Cell Squeeze Technology to generate new cell therapy concepts in multiple disease areas from cancer to regenerative medicine. In previous roles he lead Business Development as well as managing active partnerships such as the >$1B Collaboration with Roche. Dr.

Jonathan Gilbert

VP of Exploratory Research
SQZ Biotechnologies

Jonathan Gilbert

VP of Exploratory Research
SQZ Biotechnologies

Jonathan Gilbert, PhD joined SQZ in 2013 and has been a key player in the growth and development of the company from its formative stages. As the Vice President of Exploratory Research, he is applying the Cell Squeeze Technology to generate new cell therapy concepts in multiple disease areas from cancer to regenerative medicine. In previous roles he lead Business Development as well as managing active partnerships such as the >$1B Collaboration with Roche. Dr. Gilbert received his PhD in Chemical Engineering from MIT, where he was a Presidential Fellow, and studied biomedical applications of structured polyelectrolyte films with Professor Robert Cohen and Professor Michael Rubner. He has published over a dozen articles and is an inventor on 8 patents.